Article ; Online: An Updated Insight into Phytomolecules and Novel Approaches used in the Management of Breast Cancer.
2024 Volume 25, Issue 3, Page(s) 201–219
Abstract: Breast cancer is a widespread condition that kills more women from cancer-related causes than any other type of cancer globally. Women who have estrogen-dependent, initial metastatic breast cancer frequently receive treatment with surgery, radiation ... ...
Abstract | Breast cancer is a widespread condition that kills more women from cancer-related causes than any other type of cancer globally. Women who have estrogen-dependent, initial metastatic breast cancer frequently receive treatment with surgery, radiation therapy, and chemotherapy. They may also get more specialized treatments like tamoxifen or aromatase inhibitors (anastrozole or letrozole). The World Health Organisation reported in 2012 that by 2030, breast cancer will be more common worldwide. There are several phytochemicals, such as isoflavones, coumestans, lignans, and prenylflavonoides. Isoflavones have been shown in studies to prevent the spread of breast cancer and to trigger apoptosis. Targeting BCs in metastatic breast cancer may be made possible by combining well-formulated phytochemicals in nanoparticles or other novel drug delivery agents with currently accepted endocrine and/or conventional chemotherapies. Cell signaling, regulation of cell cycles, oxidative stress action, and inflammation could be positively impacted by phytoconstituents. They have the ability to alter non-coding RNAs, to prevent the proliferation and regeneration of cancer cells. The availability of novel approaches helps in disease targeting, safety, effectiveness and efficacy. The current literature helps to know the available drugs i.e. phytoconstituents or novel drug delivery like nanoparticle, microsphere, micelles, liposomes and neosomes. The literature has been taken from PubMed, Google Scholar, SciFinder, or other internet sites. |
---|---|
MeSH term(s) | Humans ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Female ; Phytochemicals/pharmacology ; Phytochemicals/therapeutic use ; Phytochemicals/chemistry ; Drug Delivery Systems ; Antineoplastic Agents, Phytogenic/therapeutic use ; Antineoplastic Agents, Phytogenic/pharmacology ; Antineoplastic Agents, Phytogenic/administration & dosage ; Nanoparticles/chemistry |
Chemical Substances | Phytochemicals ; Antineoplastic Agents, Phytogenic |
Language | English |
Publishing date | 2024-01-16 |
Publishing country | United Arab Emirates |
Document type | Journal Article ; Review |
ZDB-ID | 2064859-5 |
ISSN | 1873-5592 ; 1389-4501 |
ISSN (online) | 1873-5592 |
ISSN | 1389-4501 |
DOI | 10.2174/0113894501277556231221072938 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5578: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.